This recognition is a testament to our unparalleled manufacturing excellence and strict adherence to international regulatory guidelines. Our manufacturing facilities are genuinely world-class.” — Dr.
The European Medicines Agency has found issues at the plant of an Indian API maker that the FDA hit with a warning letter some years back. In a recent posting, the EMA noted a risk of cross ...
Micro Labs USA and Saptalis Pharmaceuticals, are introducing Metformin oral solution. "After the successful launch of Clobetasol topical solution, Micro Labs is once again very excited to collaborate ...
Six months after the FDA banned a Micro Labs plant in India for a variety of quality issues, the drugmaker is recalling nearly 55,000 bottles of generic Lipitor from another of its facilities for ...
Esperion settles patent litigation with Micro Labs, extending protection for NEXLETOL until April 2040, with ongoing litigation against other defendants. Esperion has reached a settlement with Micro ...
ANN ARBOR, Mich., May 12, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it has entered into a settlement agreement with Micro Labs USA, Inc. and its affiliate Micro Labs ...
The Food and Drug Administration has approved two applications for the first generics of Bristol-Myers Squibb's Eliquis (apixaban) tablets to reduce the risk of stroke and systemic embolism in ...
Bengaluru-based pharmaceuticals firm Micro Labs Ltd, one of the largest privately held pharma companies in India, is close to acquiring a Nigerian pharmaceuticals company, in what could be its second ...
Karnataka’s pharma major, Micro Labs concerned about the rising hypertension cases in the country, is launching is ‘I am on Salt Satyagraha,’ an initiative to educate people about the connection ...
Micro Labs Limited was honored as“India's Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company of the Year 2024 This recognition is a testament to our unparalleled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results